No Products on your Comparison List.
Your basket is empty.
Find out more
Inhibitor of angiogenesis. Additionally we are shipping Platelet Factor 4 Variant 1 Kits (26) and Platelet Factor 4 Variant 1 Proteins (11) and many more products for this protein.
Showing 10 out of 31 products:
Human Polyclonal PF4V1 Primary Antibody for WB - ABIN2777124
Struyf, Burdick, Proost, Van Damme, Strieter: Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. in Circulation research 2004
fibstatin and CXCL4L1 have cooperative roles in inhibition of tumor invasion in lymph nodes
CXCL4 and CXCL4L1 activated p38 MAPK, as well as Src kinase within 30 and 5 min, respectively. Extracellular signal-regulated kinase (ERK) phosphorylation occurred in activated lymphocytes.
Structural insight into the novel functional properties of human CXCL4L1.
PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function
Current knowledge on the role of CXCL4/PF-4 and CXCL4L1/PF-4var in physiological and pathological processes.
CXCL4L1 may act angiostatically causing random endothelial cell locomotion, disturbing directed migration towards angiogenic chemokines, serving as a homeostatic chemokine with moderate structural distinction yet different functional profile from CXCL4.
both CXCR3A and CXCR3B are implicated in the chemotactic and vascular effects of CXCL4L1.
The study determines the binding parameters of CXCL4 and CXCL4L1 for heparin, heparan sulfate, and chondroitin sulfate B.
Inhibitor of angiogenesis. Inhibitor of endothelial cell chemotaxis (in vitro).
C-X-C motif chemokine 4
, platelet factor 4 variant
, platelet factor 4, variant 1 (PF4-like)
, platelet factor 4 variant 1